91影库

Annual Meeting

Enzymes: Still cool after all these years

Learn about the Discover BMB 2024 symposium on enzymes
Shelley Copley Hung-wen (Ben) Liu
By Shelley Copley and Hung-wen (Ben) Liu
Sept. 12, 2023

The first enzyme was discovered in 1833, almost 200 years ago and long before the nature of proteins was appreciated. The field of enzymology came into its own in the 20th century. Technological advances in the hands of creative enzymologists led to an ever-growing understanding of how enzymes achieve enormous rate accelerations as well as the structural basis for substrate specificity and allosteric regulation.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.

Enzymologists continue to break new ground as we enter the 21st century. Our session at Discover BMB will feature new work on enzyme functions, mechanisms and applications.

Our first group of speakers will focus on enzymes that deal with problems caused by misbehaving metabolites. They will describe how enzymes can protect unstable intermediates and repair damaged metabolites.  Our second group will explore the potential of using enzymes for biodegradation and green biosynthesis of chemicals currently produced from petrochemicals. Our final group will focus on enzymes that catalyze novel reactions, pushing the boundaries of chemistry accessible through biocatalysts.

Keywords: Substrate channeling, metabolite repair, biodegradation, green chemistry, natural product biosynthesis, radical chemistry.

Who should attend: Anyone who appreciates the awesome power of enzyme catalysis.

Theme song: by Paul Simon, because enzymes are crazy-efficient catalysts

This session is powered by the ribosome, which produces the enzymes that make life possible.

Cool and novel enzymes

Enzymatic control of problematic intermediates

Chair: Hung-Wen (Ben) Liu

Shelley D. CopleyUniversity of Colorado Boulder

Tom NiehausUniversity of Minnesota, Twin Cities

Shelley MinteerUniversity of Utah

Carole LinsterUniversity of Luxembourg

Enzymes for a sustainable future

Chair: Shelley D. Copley

Gregg BeckhamNational Renewable Energy Laboratory

Larry WackettUniversity of Minnesota

Michelle Chang, University of California, Berkeley

Raquel Lieberman, Georgia Institute of Technology

New and unusual enzymatic transformations

Chair: Michelle Chang

Hung-wen (Ben) LiuUniversity of Texas at Austin

Aimin LiuUniversity of Texas at San Antonio

Sara O'ConnorMax Planck Institute for Chemical Ecology

Wenjun ZhangUniversity of California, Berkeley

Enjoy reading 91影库Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Shelley Copley
Shelley Copley

Shelley Copley is a professor in the molecular, cellular and developmental biology department and a fellow of the Cooperative Institute for Environmental Sciences at the University of Colorado Boulder.

Hung-wen (Ben) Liu
Hung-wen (Ben) Liu

Hung-wen (Ben) Liu is a professor in the College of Pharmacy and chemistry department of the University of Texas at Austin.

Related articles

Out with the old, in with the nucleus
Glen Liszczak & Aaron Johnson
Biochemists face the climate challenge
Karla Neugebauer & Kayunta Johnson鈥揥inters
Building natural products
Yi Tang & Katherine Ryan
Enzymes show off new moves
Tadhg Begley & Catherine Drennan

Get the latest from 91影库Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
News

Cracking cancer鈥檚 code through functional connections

July 2, 2025

A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17鈥21 in Cambridge, Massachusetts.